Fennelly Joseph T, Gourbault Lysander J, Stedman Tobias, Price Michael J, Ward Alex E
Stoke Mandeville Hospital, Mandeville Road, Aylesbury, HP21 8AL, United Kingdom.
John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, United Kingdom.
Surgeon. 2021 Oct;19(5):e237-e244. doi: 10.1016/j.surge.2020.11.001. Epub 2021 Jan 5.
Ankle fractures are one of the most common fractures in adults aged 20-65 years. The British Orthopaedic Association (BOA) and British Orthopaedic Foot and Ankle Society (BOFAS) jointly produced Standards for Trauma (BOAST) BOAST 12, with the aim of reducing morbidity by standardising care of these injuries. The primary aim of the AUGMENT study was to determine the extent and clinical effect of variation from BOAST 12.
AUGMENT was a multi-centre prospective trainee led audit of consecutive patients presenting with an ankle fracture within a four-week period. Data were collected on patient demographics, comorbidities, management and 12-week outcome. The BOAST 12 standards were divided into four subgroups; documentation, imaging, management and follow-up. Percentage compliance with each subgroup was analysed. A multivariate logistic regression analysis was used to determine impact of overall compliance on likelihood of discharge in follow-up period.
971 patients were included across 52 sites. The overall rate of BOAST 12 compliance was 41.7%. Variations in practice were observed in clinical documentation, especially of neurovascular status, (40.7%) and VTE assessment (61.5%). Patient management compliance with all 16 of the BOAST 12 standards was associated with a higher rate of discharge during the 12-week follow-up period (p = 0.005).
AUGMENT has demonstrated that the management of ankle fractures is variable across the UK. Over half of patients had aspects of their care that were not BOAST 12 compliant. When compliance was observed, it was associated with earlier discharge from orthopaedic care.
踝关节骨折是20至65岁成年人中最常见的骨折之一。英国骨科协会(BOA)和英国足踝骨科协会(BOFAS)联合制定了创伤标准(BOAST)BOAST 12,旨在通过规范这些损伤的治疗来降低发病率。AUGMENT研究的主要目的是确定与BOAST 12的差异程度及其临床影响。
AUGMENT是一项由多中心的实习医生主导的前瞻性审计,对四周内连续出现踝关节骨折的患者进行研究。收集了患者的人口统计学数据、合并症、治疗情况和12周的结果。BOAST 12标准分为四个亚组:记录、影像学检查、治疗和随访。分析了每个亚组的依从率。采用多变量逻辑回归分析来确定总体依从性对随访期出院可能性的影响。
52个地点共纳入971例患者。BOAST 12的总体依从率为41.7%。在临床记录方面观察到实践差异,尤其是神经血管状况(40.7%)和VTE评估(61.5%)。在12周的随访期内,患者治疗符合BOAST 12的所有16项标准与更高的出院率相关(p = 0.005)。
AUGMENT表明,英国各地踝关节骨折的治疗存在差异。超过一半的患者在护理方面存在不符合BOAST 12的情况。当观察到依从性时,它与骨科护理的早期出院相关。